Search Results - "Tzeng, Alice"
-
1
Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer
Published in Genome medicine (16-04-2021)“…Currently, over half of breast cancer cases are unrelated to known risk factors, highlighting the importance of discovering other cancer-promoting factors…”
Get full text
Journal Article -
2
Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
Published in Proceedings of the National Academy of Sciences - PNAS (17-03-2015)“…Cytokine therapy can activate potent, sustained antitumor responses, but collateral toxicity often limits dosages. Although antibody–cytokine fusions…”
Get full text
Journal Article -
3
The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice
Published in PloS one (17-11-2011)“…The presence of a complex and diverse intestinal flora is functionally important for regulating intestinal mucosal immune responses. However, the extent to…”
Get full text
Journal Article -
4
Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
Published in Journal for immunotherapy of cancer (01-10-2021)“…While immune checkpoint inhibitors (ICI) can lead to sustained responses in metastatic renal cell carcinoma (mRCC), the optimal duration of therapy remains…”
Get full text
Journal Article -
5
Prevention of pulmonary morbidity for patients with neuromuscular disease
Published in Chest (01-11-2000)“…To evaluate the effects of a respiratory muscle aid protocol on hospitalization rates for respiratory complications of neuromuscular disease. A retrospective…”
Get more information
Journal Article -
6
Fecal microbiota of adolescent and young adult cancer survivors and metabolic syndrome: an exploratory study
Published in Pediatric hematology and oncology (10-03-2022)“…Metabolic syndrome and obesity occur commonly in long-term pediatric cancer survivors. The intestinal microbiome is associated with metabolic syndrome and…”
Get full text
Journal Article -
7
Order of administration of combination cytokine therapies can decouple toxicity from efficacy in syngeneic mouse tumor models
Published in Oncoimmunology (04-05-2019)“…In combination cancer immunotherapies, consideration should be given to designing treatment schedules that harmonize with the immune system's natural timing…”
Get full text
Journal Article -
8
Immunological Correlates of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
Published in Targeted oncology (01-10-2018)“…Background The identification of prognostic and/or predictive biomarkers for response to immune checkpoint inhibitors (ICI) could help guide treatment…”
Get full text
Journal Article -
9
Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study
Published in JTO clinical and research reports (01-10-2023)“…Thoracic radiotherapy (TRT) is increasingly used in patients receiving osimertinib for advanced NSCLC, and the risk of pneumonitis is not established. We…”
Get full text
Journal Article -
10
The Role of Patient Activation in Achieving Better Outcomes and Cost-Effectiveness in Patient Care
Published in JBJS reviews (27-01-2015)Get full text
Journal Article -
11
Neuromuscular ventilatory insufficiency : Effect of home mechanical ventilator use v oxygen therapy on pneumonia and hospitalization rates
Published in American journal of physical medicine & rehabilitation (01-01-1998)“…The purpose of this study was to determine rates of pneumonia and hospitalization for patients receiving oxygen therapy, patients having indwelling…”
Get full text
Journal Article -
12
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Published in Nature medicine (01-12-2016)“…An immunotherapy consisting of a tumor-antigen targeting antibody, PD-1 blocking antibody, extended half-life recombinant IL-2 and a lymph-node-targeted T cell…”
Get full text
Journal Article -
13
Treating periprosthetic joint infections as biofilms: key diagnosis and management strategies
Published in Diagnostic microbiology and infectious disease (01-03-2015)“…Abstract Considerable evidence suggests that microbial biofilms play an important role in periprosthetic joint infection (PJI) pathogenesis. Compared to…”
Get full text
Journal Article -
14
A study of thyrotropin-releasing hormone for the treatment of spinal muscular atrophy: A preliminary report
Published in American journal of physical medicine & rehabilitation (01-09-2000)“…To determine whether thyrotropin-releasing hormone (TRH) can increase muscle strength in children with spinal muscular atrophy types 2 and 3. A randomized,…”
Get full text
Journal Article -
15
Immunological correlates of response and immune-mediated toxicity in checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts)
Published in Journal of clinical oncology (20-02-2022)“…Abstract only 526 Background: Myeloid derived suppressors cells (MDSC) are immune cells that create an immunosuppressive microenvironment. Increased expression…”
Get full text
Journal Article -
16
Interplay Between Class II HLA Genotypes and the Microbiome and Immune Phenotypes in Individuals With PTEN Hamartoma Tumor Syndrome
Published in JCO precision oncology (2021)“…We evaluate potential contributors to the development of autoimmunity and other phenotypes consistent with immune dysregulation in individuals with germline…”
Get more information
Journal Article -
17
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses
Published in The Journal of experimental medicine (05-06-2017)“…Certain RGD-binding integrins are required for cell adhesion, migration, and proliferation and are overexpressed in most tumors, making them attractive…”
Get full text
Journal Article -
18
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events
Published in Clinical genitourinary cancer (01-04-2024)“…As most patients with metastatic urothelial carcinoma (mUC) will be treated with immune checkpoint inhibitors (ICI), familiarity with their associated…”
Get full text
Journal Article -
19
Temporally Programmed CD8α+ DC Activation Enhances Combination Cancer Immunotherapy
Published in Cell reports (Cambridge) (06-12-2016)“…Numerous synergistic cancer immunotherapy combinations have been identified, but the effects of relative dose timing are rarely considered. In established…”
Get full text
Journal Article -
20
Immunological correlates of response to immune checkpoint inhibitors (ICI) in metastatic urothelial carcinoma (mUC) patients (pts)
Published in Journal of clinical oncology (20-02-2018)“…Abstract only 454 Background: Identification of biomarkers predictive of response to ICI could help guide treatment (tx) decisions. We assessed the correlation…”
Get full text
Journal Article